Search results
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 3 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
Insider Monkey via Yahoo Finance· 3 days agoRGA Investment Advisors, an investment management company released its first quarter 2024 investor...
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
Clinical Trials Arena via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has placed a partial clinical hold on BioNTech’s Phase I...
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- The Food and Drug Administration delayed a breast- and lung-cancer trial of an...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 3 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
BioNTech SE (NASDAQ:BNTX) Shares Purchased by PARUS FINANCE UK Ltd
ETF DAILY NEWS· 6 days agoPARUS FINANCE UK Ltd increased its stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 1.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 25,974 ...
FDA halts trial of BioNTech-MediLink ADC over 'significant risk of illness'
FierceBiotech· 3 days agoThe FDA has slammed the brakes on a trial of MediLink Therapeutics’ BioNTech-partnered antibody-drug...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters· 3 days ago, opens new tab on Monday the U.S. Food and Drug Administration has placed a partial clinical hold...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 hours agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? - BioNTech (NASDAQ:BNTX)
Benzinga· 3 days agoBioNTech SE’s BNTX partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 trial. The MediLink-sponsored trial evaluates ...